# Steroid-reducing Effects of Crisaborole

> **NCT03832010** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 24 (actual)

## Conditions studied

- Atopic Dermatitis
- Eczema

## Interventions

- **DRUG:** Crisaborole
- **DRUG:** Hydrocortisone Ointment
- **DRUG:** Triamcinolone ointment
- **DRUG:** Aquaphor

## Key facts

- **NCT ID:** NCT03832010
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-17
- **Primary completion:** 2024-02-16
- **Final completion:** 2024-02-16
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03832010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03832010, "Steroid-reducing Effects of Crisaborole". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03832010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
